Results 141 to 150 of about 11,438 (231)

Synthetic cannabinoids and Renal Injury

Northern Clinics of Istanbul, 2015
openaire   +2 more sources

The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis

Addiction, Volume 121, Issue 7, Page 1653-1670, July 2026.
Abstract Background and aims The global cannabidiol (CBD) market has expanded in recent years. Several studies suggest CBD use, whether for medical or recreational purposes, is on the rise; however, no systematic assessments of its prevalence have been conducted so far. This meta‐analysis aimed to estimate the prevalence of CBD use in North America and
Sara Weidberg, Clara Iza‐Fernández, Layla Alemán‐Moussa, Andrea Krotter, Alba González‐Roz   +4 more
wiley   +1 more source

Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well-documented intoxication cases and basic pharmacological data. [PDF]

Addiction
Sommer MJ, Grafinger KE, Hermanns-Clausen M, Auwärter V.   +3 more
europepmc   +1 more source

Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment

The American Journal on Addictions, Volume 35, Issue 4, Page 543-546, July 2026.
Abstract Background and Objectives Patients using fentanyl have worse treatment outcomes; however, little is known about other drugs that complicate treatment. Methods A national survey (n = 396) was conducted using a random sample of clinicians waivered to prescribe buprenorphine in the United States.
Erin L. Winstanley, Jane M. Liebschutz, Cristina Murray‐Krezan, Galen E. Switzer, Samantha Nash, Sarah Kawasaki   +5 more
wiley   +1 more source

NMR Spectroscopic Reference Data of Synthetic Cannabinoids Sold on the Internet. [PDF]

Magn Reson Chem
Hubner EM, Schmid MG, Manojlovic V, Gattringer D, Pferschy-Wenzig EM, Kunert O.   +5 more
europepmc   +1 more source

Defining AV2‐1 as a novel pharmacological probe to target human and rodent TRPV2

British Journal of Pharmacology, Volume 183, Issue 13, Page 3538-3557, July 2026.
Abstract Background and Purpose Transient receptor potential vanilloid 2 (TRPV2) is a non‐selective cation channel implicated in immune cell functions. However, progress in understanding TRPV2 has been limited by a lack of potent and selective pharmacological tools, particularly those targeting the human variant. We aimed to identify and characterise a
Andrea Leipe, Julia A. Rocereta, Ruth A. Pumroy, Andreas Leffler, Michael Schaefer, Vera Moiseenkova‐Bell, Kerstin Hill   +6 more
wiley   +1 more source

Systematic Characterization of In Vitro and In Vivo Metabolic Pathways and Identification of Novel Biomarkers of 26 Synthetic Cannabinoids. [PDF]

Molecules
Ning Y, Wang T, Yang X, Guo F, Xu Y, Zhang Y, Wang K, Hu M, Chen Z, Wei Z, Yun K.   +10 more
europepmc   +1 more source

Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Protocol and Cohort Profile for the Prison Outcomes STudy (POST)

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction We have been funded to examine post‐incarceration health and social outcomes for all people incarcerated in New South Wales, Australia, 2000–2022; assess treatment and services for drug dependence and serious mental illness; and project the impact of expanding intervention coverage. We will use a linked cohort, the Prison Outcomes
Louisa Degenhardt, Michael Farrell, Michael Doyle, Jack Stone, Chrianna Bharat, Matt Hickman, Marianne Martinello, Don Weatherburn, Kimberlie Dean, Joe Coyte, Christel Macdonald, Mary Ellen Harrod, Luke Grant, Gloria Larman, Peter Vickerman, Colette McGrath, Peter Thompson, Alison Churchill, Greg Dore, Thomas Santo Jr   +19 more
wiley   +1 more source

Ocular effects of synthetic cannabinoids: a case-control study. [PDF]

Eye (Lond)
Kunduracı MS, Kırık F, Onur IU, Onur OS, Karsidag C, Yigit FU, Erkiran M.   +6 more
europepmc   +1 more source

The Detection of Novel Nitazene‐Class Opioids in Unregulated Drug Markets in Canada

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction Nitazenes, a highly potent class of synthetic opioids, have emerged in Canadian unregulated drug markets. We report on their presence and composition, along with overdose trends. Methods Samples were obtained from January 2019 to July 2024 from two drug checking services (Toronto's Drug Checking Service (TDCS) and drug checking ...
Emily A. Gelgoot, Kristy M. Scarfone, Nazlee Maghsoudi, Karen McDonald, Wenqing Hao, Cristiana Stefan, Daniel R. Beriault, Sarah R. Delaney, Lianping Ti, Samuel Tobias, Jeanette M. Bowles, Dan Werb, Members of Toronto's Drug Checking Service   +12 more
wiley   +1 more source